Any feedback?
Literature summary for 4.2.1.2 extracted from
- Sepharose derivatives containing citric acid as affinity ligand. Purification of fumarase (1985), J. Chromatogr., 319, 173-185.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| citrylpolymethylenediamine | - |
Sus scrofa |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Sus scrofa | - |
- |
- |
Purification (Commentary)
| Purification (Comment) | Organism |
|---|---|
| affinity chromatography with Sepharose derivatives containing citric acid. The purification is dependent on the length of the spacer arm, but not on the isomeric configuration of the immobilized citrate | Sus scrofa |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| heart | - |
Sus scrofa | - |
Specific Activity [micromol/min/mg]
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| additional information | - |
- |
Sus scrofa |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| (S)-malate | - |
Sus scrofa | fumarate + H2O | - |
? |  |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
